scispace - formally typeset
Journal ArticleDOI

The interferon signature in autoimmune diseases.

Lars Rönnblom, +1 more
- 01 Mar 2013 - 
- Vol. 25, Iss: 2, pp 248-253
Reads0
Chats0
TLDR
The observed IFN signature in several autoimmune diseases is a biomarker of active disease and is investigated as a tool when selecting treatment for individual patients.
Abstract
Purpose of reviewAn increased expression of type I interferon (IFN) regulated genes (an IFN signature) has been reported in blood and tissue cells from patients with SLE and other autoimmune diseases. We review the possible mechanisms behind the IFN signature as well as clinical and therapeutic cons

read more

Citations
More filters
Journal ArticleDOI

Interferon Signature in the Blood in Inflammatory Common Variable Immune Deficiency

TL;DR: The unbiased use of whole blood transcriptome analysis may provides a tool for distinguishing CVID subjects who are at risk for increased morbidity and earlier mortality, and could provide an efficient means of monitoring the effects of treatment of the inflammatory phenotype.
Journal ArticleDOI

Genetics and novel aspects of therapies in systemic lupus erythematosus

TL;DR: The genetic aspects of this autoimmune disease are reviewed, clinical aspects of SLE are summarized and a general overview of conventional and new therapeutic approaches in SLE is provided.
Journal ArticleDOI

Immunological loss-of-function due to genetic gain-of-function in humans: autosomal dominance of the third kind

TL;DR: The number of genetically defined autosomal dominant PIDs has increased more rapidly than that of any other type of PID, and experiments of nature provide a unique insight into the quantitative regulation of human immunity.
Journal ArticleDOI

Childhood onset systemic lupus erythematosus: how is it different from adult SLE?

TL;DR: Clinical and immunological aspects of childhood lupus erythematosus and how it differs from adulthood SLE are reviewed.
Journal ArticleDOI

Interferon gamma in autoimmunity: A complicated player on a complex stage

TL;DR: It is now clear that IFNγ is capable of both pro- and anti-inflammatory activities with the functional outcome dependent on the physiological and pathological setting examined.
References
More filters
Journal ArticleDOI

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

TL;DR: Global gene expression profiling of peripheral blood mononuclear cells is used to identify distinct patterns of gene expression that distinguish most SLE patients from healthy controls, and identify a subgroup of patients who may benefit from therapies targeting the IFN pathway.
Journal ArticleDOI

Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood

TL;DR: Microarray analysis of blood cells reveals that immature granulocytes may be involved in SLE pathogenesis, and the IFN signature confirms the central role of this cytokine in Sle, using oligonucleotide microarrays.
Journal ArticleDOI

JAK and STAT Signaling Molecules in Immunoregulation and Immune-Mediated Disease

TL;DR: Not only have genome-wide association studies demonstrated that this pathway is highly relevant to human autoimmunity, but targeting JAKs is now a reality in immune-mediated disease.
Related Papers (5)